Degarelix is a hormonal therapy used in the treatment of prostate cancer.degarelix has an immediate onset of action, binding to gonadotropin-releasing hormone (gnrh) receptors in the pituitary gland and blocking their interaction with gnrh. this induces a fast and profound reduction in luteinising hormone (lh), follicle-stimulating hormone (fsh) and in turn, testosterone suppression.